Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RACHNA SHROFF and VIVEK SUBBIAH.
RACHNA SHROFF
Connection Strength
0.303
VIVEK SUBBIAH
  1. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 2018 01; 118(2):e2.
    View in: PubMed
    Score: 0.155
  2. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 2017 05 23; 116(11):1402-1407.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.